Skip to main content

Utility Nav

  • About Us
    • Blog
    • History
    • Administrative Leaders
    • Clinical Leaders
    • Research Leaders
    • External Advisory Committee
    • Administrative Offices
    • Care Connect
    • News & Publications
    • Events
    • International Partners
    • Careers
  • Locations
  • Contact Us
  • Giving
  • Patient Portal
  • Katz School of Medicine

Utility Nav 2

  • Find a Doctor
  • Request Appointment
  • 888-369-2427

Main navigation

  • Clinical Care
    • Why Choose Fox Chase
    • Cancer Types & Conditions
    • Prevention & Screening
    • Support
    • Clinical Trials
    • Departments
    • Patient Stories
  • Research & Training
    • Overview
    • Scientists
    • Faculty Publications
    • Research Programs
    • Research Institutes
    • Clinical Trials & Research
    • Facilities
    • Training & Education
  • Patients & Visitors
    • Appointments
    • Insurance & Financial Information
    • Visitor Information
    • Locations
    • Partners
    • International Patients
    • Where to Stay
  • Healthcare Professionals
    • Refer a Patient
    • Physician Resources
    • Key Account Managers
    • Care Connect for Physicians
    • Continuing Education
    • Careers
    • eNewsletters
  • Community
    • Volunteer
    • Community Outreach
    • Community Health
    • Patient and Family Advisory Council
    • Walk & Run Events
888-369-2427

Utility Nav 2

  • Find a Doctor
  • Request Appointment
  • 888-369-2427
  • main menu
    Back One Level
  • Technology Licensing
  • Cancer Therapeutics and Discovery Targets
    • main menu
      Back One Level
    • Cancer Therapeutics and Discovery Targets
    • A Highly Specific Antibody Targeting Tumor Endothelial Marker 7R
    • ATR KINASE: A NOVEL CELLULAR TARGET FOR ANTI-RETROVIRAL DRUG DISCOVERY AND THERAPY
    • C-MYC as a Novel Biomarker of Cancer Therapeutic Efficacy
    • Cholesterol synthesis inhibitors synergize with Smoothened antagonist for treatment of Hedgehog pathway malignancies
    • Combination Therapy for the Treatment of Cancer
    • Combination of Sunitinib with Farnesyl-Transferase Inhibitors as a Next Generation Therapeutic Approach
    • Combined Inhibition of DNA Replication and Vitamin D Receptor in Cancer Treatment
    • Combined Inhibition of the Vitamin D Receptor and Poly-ADP Ribose Polymerase (PARP) in the Treatment of Cancer
    • Identification of Putative Interacting Components in Complex Pathways
    • Method of Detection the Therapeutic Response in Solid Tumors
    • Methods to Treat Hepatitis B and Other Liver Disorders
    • MicroRNAs Targeting CDK4 /6 -Cell Cycle P athway as Treatment for Cancer
    • New Anticancer Zinc Chetatin Agents for Therapy of Advanced Prostate Cancer
    • New Chimeric Human Chorionic Gonadotropin Variant Peptides in Combination Therapy of Breast Cancer
    • New Compounds Repressing Cancer Cell Growth
    • New Drug Target S ite of HIV I ntegrase for AIDS Therapy
    • New Method for Colorectal Cancer Diagnosis and Treatment
    • New Method for Treatment of Cancer
    • Novel Biomarkers for Prognosis and Diagnosis of Prostate Cancer
    • Novel Class of PARP-1 Blockers for the Treatment of Prostate and Renal cancers
    • Novel Combinatorial Treatment of Cancer
    • Novel Druggable Targets on the Interface of Oncogenic and Metabolic Pathways
    • Novel Methods for Inhibiting Growth and Proliferation of Melanoma Cells
    • Novel Precision Immuno-Therapy of Cancer
    • Novel TRAIL-upregulating miRNA for Treating Cancer
    • Novel Treatment of Medulloblastoma with Leukotriene Inhibitors
    • Prodigiosin Analogs as Cancer Therapeutics
    • Rational Design of Novel Anti-Cancer Therapeutic Proteins
    • Rationally Designed Anti-Mullerian Inhibiting Substance Type II Receptor Antibodies
    • Re-evaluating strategies of cancer treatment based on a novel class of H4-dependent PARP-1 inhibitors
    • Secreted/Cell Bound Poxvirus Proteins and Methods of Use Thereof as Vaccines and Antiviral Agents
    • Small Molecule Allosteric Inhibitors of HIV Integrase
    • TREATMENT OF DISEASES ASSOCIATED WITH ABERRANT CILIARY FUNCTION
    • Targeted Therapy for Ovarian Cancer
    • Targeting of Cytochrome CYP1B1 in the Treatment of Head and Neck and Lung cancers
    • Urinary DNA Detection for Monitoring of Urothelial Cancer
    • Viral-based cancer gene therapy and treatment of influenza infection through induction of cell death
  • Cancer Diagnostics and Risk Assessment
    • main menu
      Back One Level
    • Cancer Diagnostics and Risk Assessment
    • A novel risk-assessment method for colorectal cancer and prostate cancer
    • Biomarkers for Early Pancreatic Cancer Detection and Treatment
    • Method of Detection the Therapeutic Response in Solid Tumors
    • New Method for Colorectal Cancer Diagnosis and Treatment
    • Novel Biomarkers for Prognosis and Diagnosis of Prostate Cancer
    • Novel Biomarker for Risk Assessment and Treatment Evaluation for Cancers with Fibrosis Predispositions
    • Novel Cancer Prognostic based on MHC-I Genotype and Presentability
    • Novel Diagnostic and Prognostic Marker for Malignant Mesothelioma
    • Novel Screening Biomarkers for Muscle Invasive Bladder Cancer Response to Chemotherapy
    • Urinary DNA Detection for Monitoring of Urothelial Cancer
  • Gene Therapy
    • main menu
      Back One Level
    • Gene Therapy
    • Novel Gene Therapy for Treating Cystathionine Beta-Synthase Enzyme Deficiency in Homocystinuria
  • COVID Therapeutics and Diagnostics
  • Medical Devices
    • main menu
      Back One Level
    • Medical Devices
    • Aromatherapy Device / Wrist Mate
    • Endoscopic Device for Diagnosis and Tissue Sampling of Neoplasia in Urinary Bladder
    • HematoDart – A Novel Applicator for Hemostatic Agents
    • HematoStick – A Novel Applicator for Hemostasis
    • Method and Apparatus for Endoscopic Examination of Lesions in Small Animals
    • Multipurpose Device for Prophylaxis and Treating Vascular and Respiratory Disorders
    • Nasal Cannula Adapter for Post-Surgical Patient Gas Administration
    • Sequential Manual Compression Device for Treatment or Prevention of Deep Vein Thrombosis
    • System for Fusion of Fluorescence Molecular Tomography and Magnetic Resonance Images
    • Tensional Surgical Clamp
  • Digital Health
    • main menu
      Back One Level
    • Digital Health
    • Method and System for Identifying Retained Surgical Items
    • Nomogram
  • Tangible Research Materials
    • main menu
      Back One Level
    • Tangible Research Materials
    • Antibodies
    • Cell Lines
    • Other Research Materials
  • Animal & PDX Models
    • main menu
      Back One Level
    • Animal & PDX Models
    • Mice with Transgene of Obox Peptide Inhibitor of Group B P21-Activated Kinases
    • TetOp16 Transgenic Mouse Model for Cell Proliferation
    • p21-Activated Kinase Inhibitor Domain Targeted Transgenic Mouse
  • Research Methods, Screens and Assays
    • main menu
      Back One Level
    • Research Methods, Screens and Assays
    • Carbon-Detected NMR for Mapping Binding Sites in Intrinsically Disordered Regions of a Protein
    • Method and Apparatus for Endoscopic Examination of Lesions in Small Animals
    • Methods of Inhibiting Proliferation of Estrogen-Independent Cancer Cells
    • Multi-Analyte Columns – Generating a Kinome Profile for Cancer Therapy
    • Novel method of selection and enrichment of gene-targeted cells
    • Screening Assay for Identification of Poly-ADP Ribose Polymerase 1(PARP1) Inhibitors
    • Three-Dimensional Cell-Derived Extracellular Matrix/Gel Systems

Breadcrumb

  1. Home
  2. About Us
  3. R&D Alliances
  4. Technology Transfer
  5. Technologies Available for Licensing and/or Research Collaborations
  • Technology Licensing
    • Cancer Therapeutics and Discovery Targets
      • A Highly Specific Antibody Targeting Tumor Endothelial Marker 7R
      • ATR KINASE: A NOVEL CELLULAR TARGET FOR ANTI-RETROVIRAL DRUG DISCOVERY AND THERAPY
      • C-MYC as a Novel Biomarker of Cancer Therapeutic Efficacy
      • Cholesterol synthesis inhibitors synergize with Smoothened antagonist for treatment of Hedgehog pathway malignancies
      • Combination Therapy for the Treatment of Cancer
      • Combination of Sunitinib with Farnesyl-Transferase Inhibitors as a Next Generation Therapeutic Approach
      • Combined Inhibition of DNA Replication and Vitamin D Receptor in Cancer Treatment
      • Combined Inhibition of the Vitamin D Receptor and Poly-ADP Ribose Polymerase (PARP) in the Treatment of Cancer
      • Identification of Putative Interacting Components in Complex Pathways
      • Method of Detection the Therapeutic Response in Solid Tumors
      • Methods to Treat Hepatitis B and Other Liver Disorders
      • MicroRNAs Targeting CDK4 /6 -Cell Cycle P athway as Treatment for Cancer
      • New Anticancer Zinc Chetatin Agents for Therapy of Advanced Prostate Cancer
      • New Chimeric Human Chorionic Gonadotropin Variant Peptides in Combination Therapy of Breast Cancer
      • New Compounds Repressing Cancer Cell Growth
      • New Drug Target S ite of HIV I ntegrase for AIDS Therapy
      • New Method for Colorectal Cancer Diagnosis and Treatment
      • New Method for Treatment of Cancer
      • Novel Biomarkers for Prognosis and Diagnosis of Prostate Cancer
      • Novel Class of PARP-1 Blockers for the Treatment of Prostate and Renal cancers
      • Novel Combinatorial Treatment of Cancer
      • Novel Druggable Targets on the Interface of Oncogenic and Metabolic Pathways
      • Novel Methods for Inhibiting Growth and Proliferation of Melanoma Cells
      • Novel Precision Immuno-Therapy of Cancer
      • Novel TRAIL-upregulating miRNA for Treating Cancer
      • Novel Treatment of Medulloblastoma with Leukotriene Inhibitors
      • Prodigiosin Analogs as Cancer Therapeutics
      • Rational Design of Novel Anti-Cancer Therapeutic Proteins
      • Rationally Designed Anti-Mullerian Inhibiting Substance Type II Receptor Antibodies
      • Re-evaluating strategies of cancer treatment based on a novel class of H4-dependent PARP-1 inhibitors
      • Secreted/Cell Bound Poxvirus Proteins and Methods of Use Thereof as Vaccines and Antiviral Agents
      • Small Molecule Allosteric Inhibitors of HIV Integrase
      • TREATMENT OF DISEASES ASSOCIATED WITH ABERRANT CILIARY FUNCTION
      • Targeted Therapy for Ovarian Cancer
      • Targeting of Cytochrome CYP1B1 in the Treatment of Head and Neck and Lung cancers
      • Urinary DNA Detection for Monitoring of Urothelial Cancer
      • Viral-based cancer gene therapy and treatment of influenza infection through induction of cell death
    • Cancer Diagnostics and Risk Assessment
      • A novel risk-assessment method for colorectal cancer and prostate cancer
      • Biomarkers for Early Pancreatic Cancer Detection and Treatment
      • Method of Detection the Therapeutic Response in Solid Tumors
      • New Method for Colorectal Cancer Diagnosis and Treatment
      • Novel Biomarkers for Prognosis and Diagnosis of Prostate Cancer
      • Novel Biomarker for Risk Assessment and Treatment Evaluation for Cancers with Fibrosis Predispositions
      • Novel Cancer Prognostic based on MHC-I Genotype and Presentability
      • Novel Diagnostic and Prognostic Marker for Malignant Mesothelioma
      • Novel Screening Biomarkers for Muscle Invasive Bladder Cancer Response to Chemotherapy
      • Urinary DNA Detection for Monitoring of Urothelial Cancer
    • Gene Therapy
      • Novel Gene Therapy for Treating Cystathionine Beta-Synthase Enzyme Deficiency in Homocystinuria
    • COVID Therapeutics and Diagnostics
    • Medical Devices
      • Aromatherapy Device / Wrist Mate
      • Endoscopic Device for Diagnosis and Tissue Sampling of Neoplasia in Urinary Bladder
      • HematoDart – A Novel Applicator for Hemostatic Agents
      • HematoStick – A Novel Applicator for Hemostasis
      • Method and Apparatus for Endoscopic Examination of Lesions in Small Animals
      • Multipurpose Device for Prophylaxis and Treating Vascular and Respiratory Disorders
      • Nasal Cannula Adapter for Post-Surgical Patient Gas Administration
      • Sequential Manual Compression Device for Treatment or Prevention of Deep Vein Thrombosis
      • System for Fusion of Fluorescence Molecular Tomography and Magnetic Resonance Images
      • Tensional Surgical Clamp
    • Digital Health
      • Method and System for Identifying Retained Surgical Items
      • Nomogram
    • Tangible Research Materials
      • Antibodies
      • Cell Lines
      • Other Research Materials
    • Animal & PDX Models
      • Mice with Transgene of Obox Peptide Inhibitor of Group B P21-Activated Kinases
      • TetOp16 Transgenic Mouse Model for Cell Proliferation
      • p21-Activated Kinase Inhibitor Domain Targeted Transgenic Mouse
    • Research Methods, Screens and Assays
      • Carbon-Detected NMR for Mapping Binding Sites in Intrinsically Disordered Regions of a Protein
      • Method and Apparatus for Endoscopic Examination of Lesions in Small Animals
      • Methods of Inhibiting Proliferation of Estrogen-Independent Cancer Cells
      • Multi-Analyte Columns – Generating a Kinome Profile for Cancer Therapy
      • Novel method of selection and enrichment of gene-targeted cells
      • Screening Assay for Identification of Poly-ADP Ribose Polymerase 1(PARP1) Inhibitors
      • Three-Dimensional Cell-Derived Extracellular Matrix/Gel Systems

Technologies Available for Licensing and/or Research Collaborations

Cancer Therapeutics and Discovery Targets
 

Cancer Diagnostics and Risk Assessment
 

Gene Therapy
 

COVID Therapeutics and Diagnostics
 

Medical Devices
 

Digital Health
 

Animal & PDX Models
 

Tangible Research Materials

  • Antibodies

  • Cell Lines

  • Other Research Materials

Research Methods, Screens and Assays

Share
  • Share with Facebook facebook-icon
  • Share with twitter twitter-icon
  • Share with email email-icon
  • Print this print-icon
Resize Text

888-369-2427

Fox Chase Cancer Center
Main Campus
333 Cottman Avenue
Philadelphia, PA 19111-2497

Connect with Fox Chase

  • Facebook Icon
  • Twitter Icon
  • Instagram Icon
  • Linkedin Icon
  • Flickr Icon
  • Youtube Icon
  • Appointments
  • Careers
  • Contact Us
  • Pay a Bill
  • Financial Assistance/Charity Care
  • Giving
  • Patient Portal
  • Temple Health
  • Lewis Katz School of Medicine
  • Temple University
  • A National Cancer Center Comprehensive Center
    National Comprehensive Cancer Network (NCCN)

©2022 Temple University Health System, Inc., Philadelphia, Pennsylvania. All rights reserved.

Temple Health refers to the health, education and research activities carried out by the affiliates of Temple University Health System (TUHS) and by the Lewis Katz School of Medicine at Temple University. TUHS neither provides nor controls the provision of health care. All health care is provided by its member organizations or independent health care providers affiliated with TUHS member organizations. Each TUHS member organization is owned and operated pursuant to its governing documents.

  • Terms of Use
  • Patient Rights
  • Privacy & Non-Discrimination Notices
  • TUHS Vendor Policies & Procedures